<DOC>
	<DOCNO>NCT02362373</DOCNO>
	<brief_summary>The investigator conduct prospective , seven-month pilot study explore pharmacokinetic ( PK ) pharmacodynamic ( PD ) effect among woman epilepsy use levonorgestrel intrauterine system ( LNG IUS ) contraception . The investigator enroll twenty woman well-controlled epilepsy maintain stable anti-epileptic drug ( AED ) therapy seek LNG IUS contraception . The primary outcome AED level seizures LNG IUS placement . Secondary outcome include LNG level , evidence ovulation three week insertion ( serum progesterone &gt; 3ng/ml ) , bleed spotting , endometrial thickness , continuation , satisfaction adverse event ( removal , expulsion , side effect ) . The investigator conduct baseline month assessment , insertion visit , follow-up visit 21 day , three month six month .</brief_summary>
	<brief_title>Women With Epilepsy : Pilot Study PK PD Anti-epileptic Drug Effects Levonorgestrel Intrauterine System Users</brief_title>
	<detailed_description>Study Procedures This pilot study consist five study visit . Once preliminary eligibility determine telephone screen interview , first visit schedule . Visit 1 Enrollment/Baseline - Review Eligibility - Informed Consent - Collect Baseline Information - Vital Signs - Pregnancy Test - Complete Physical Exam include Pelvic exam , - Chlamydia testing , Pap test need per ASCCP ( American Society Colposcopy Cervical Pathology ) guideline - Receive diary record bleed spot - Receive condom , need , use IUS insertion - Sign release contact primary neurologist epileptologist - Study MD contact participant 's neurologist notify trial participation , verify type dose AEDs Visit 2 Insertion/4-6 Weeks Baseline - Vital Signs - Pregnancy Test - Phlebotomy hormone AED level - Transvaginal ultrasound - IUS Insertion - Review collect complete diary - Receive new diary Visit 3/ Follow 3 Weeks post IUS Insertion - Vital Signs - Phlebotomy hormone AED level - Transvaginal Ultrasound - Review collect complete diary - Receive new diary Visit 4/Follow 3 Months post IUS Insertion - Vital Signs - Phlebotomy hormone AED level - Transvaginal ultrasound - Review collect complete diary - Receive new diary - Acceptability Questionnaire Visit 5/ Exit 6 Months post IUS insertion - Vital Signs - Phlebotomy hormone AED level - Transvaginal Ultrasound - Review collect final complete diary - Acceptability Questionnaire</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>1 . Age1845 year 2 . Regular menstrual cycle length 2135 day 3 . Willing use IUS contraception 4 . Willing use nonhormonal contraception one month insertion 5 . Stable AED therapy least two month 6 . Wellcontrolled epilepsy ( 2 few seizure , simple partial , per month ) 7 . Working telephone 8 . English Speaking 1 . Current pregnancy pregnancy previous two month 2 . Breastfeeding amenorrhea 3 . Hepatic p450 enzyme induce medication AEDs ( griseofulvin , rifampin , St. John 's Wort , bosentan ) 4 . Depomedroxyprogesterone acetate within previous six month 5 . Congenital acquire uterine anomaly , include myoma , distort uterine cavity 6 . Acute pelvic infection history pelvic infection without subsequent intrauterine pregnancy 7 . Postpartum endometritis infect abortion last three month 8 . Genital bleed unknown etiology 9 . Untreated low genital tract infection ( cervical vaginal ) 10 . Acute liver disease liver tumor , benign malignant 11 . HIV infection partner HIV infection 12 . Increased susceptibility pelvic infection 13 . A previously insert intrauterine device ( IUD ) remove 14 . Hypersensitivity component LNG IUS 15 . Known suspected carcinoma breast 16 . Current abnormal cervical cytology ASCUS history abnormal cervical cytology ASCUS without appropriate followup demonstrate evidence disease 17 . History genital tract malignancy 18 . Current use anticoagulants 19 . Current alcoholism drug abuse</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>contraception</keyword>
	<keyword>drug interaction</keyword>
</DOC>